2016/09/06 - Quantum Genomics to Present at Rodman & Renshaw 18th Annual Conference in New York on September 13

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced that its Chief Executive Officer, Lionel Ségard, will present at the 18th Annual Rodman & Renshaw Global Investment Conference, being held September 11-13 in New York.

Download Press Release